Emerald BioStructures performs protein crystallization services for drug discovery organizations. Our fragment screening and fragment discovery services identify new chemical matter for modulating enzyme activity or protein-protein interactions. Our structural biology services inform medicinal chemists, strengthen intellectual property claims, and provide valuable insights that can be applied at any stage in the drug discovery pipeline.
A world-class CRO for structure-based drug design
From gene to structure, we deliver insights that support your drug discovery program
• Learn more about our services
Let us help you discover or develop new IND candidates
Peer-reviewed articles on structure-based drug design innovation
Learn about structure-based drug discovery from our experts
Expert tips on GPCR research